TF and triple-A syndrome: The identified miRNA-TF-effector gene interactions may represent key regulatory mechanisms that influence the differential expression of genes involved in angiogenesis and inflammation, contributing to the distinct molecular profiles observed in patients with LEAD, AAA, and VV.